Cerenome secures $21.3M senior secured convertible note facility with 3i Fund

PLUS THERAPEUTICS, INC.

Initial closing expected Sept 10, 2026; gross proceeds $3M; total notes $21,276,596 with 6% OID and 8% interest.
Notes convertible at $2.74/share, floor $0.50; maturity one year; secured by first-priority lien on assets and CNSide equity.
Royalty agreement: CNSide pays 2.5% of gross revenues quarterly, capped at 2.5% of outstanding note balance.
Proceeds for working capital; company forecasts cash runway into 2028; additional tranches up to $15.96M available upon milestones.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

Featured in Daily 8-K Digest

Selected #10 for 2026-09-10. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.